Your browser doesn't support javascript.
loading
Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial.
De Giorgi, Ugo; Sansovini, Maddalena; Severi, Stefano; Nicolini, Silvia; Monti, Manuela; Gurioli, Giorgia; Foca, Flavia; Casadei, Chiara; Conteduca, Vincenza; Celli, Monica; Di Iorio, Valentina; Calistri, Daniele; Matteucci, Federica; von Eyben, Finn Edler; Attard, Gerhardt; Paganelli, Giovanni.
Afiliación
  • De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy. ugo.degiorgi@irst.emr.it.
  • Sansovini M; Nuclear Medicine Operative Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Severi S; Nuclear Medicine Operative Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Nicolini S; Nuclear Medicine Operative Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Monti M; Biostatistics and Clinical Trials Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Gurioli G; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Foca F; Biostatistics and Clinical Trials Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Casadei C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Conteduca V; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Celli M; Nuclear Medicine Operative Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Di Iorio V; Oncology Pharmacy, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Calistri D; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Matteucci F; Nuclear Medicine Operative Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • von Eyben FE; Center of Tobacco Control Research, Odense M, Denmark.
  • Attard G; University College London Cancer Institute, London, UK.
  • Paganelli G; Nuclear Medicine Operative Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Br J Cancer ; 125(9): 1226-1232, 2021 10.
Article en En | MEDLINE | ID: mdl-34333554
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Androgénicos / Amplificación de Genes / Antígeno Prostático Específico / Resistencia a Antineoplásicos / Dipéptidos / Neoplasias de la Próstata Resistentes a la Castración / Compuestos Heterocíclicos con 1 Anillo Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Androgénicos / Amplificación de Genes / Antígeno Prostático Específico / Resistencia a Antineoplásicos / Dipéptidos / Neoplasias de la Próstata Resistentes a la Castración / Compuestos Heterocíclicos con 1 Anillo Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Italia